Scientific Publications Database

Article Title: Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study
Authors: Kapoor, R.; Sellebjerg, F.; Hartung, H. -P.; Arnold, D. L.; Freedman, M. S.; Jeffery, D.; Miller, A.; Edwards, K. R.; Singh, C. M.; Chang, I.; Ren, Z.; Sangurdekar, D.; Zhu, B.; Sheikh, S.; Mehta, D.; Ho, P. -R.; Campbell, N.; Edwards, M.; Fisher, E.; Kieseier, B. C.; Rudick, R. A.; Plavina, T.
Journal: MULTIPLE SCLEROSIS JOURNAL Volume 24
Date of Publication:2018
Abstract:
.